Alector, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ALEC | VYGR | ACIU | PRTA | GANX | ABOS | |
|---|---|---|---|---|---|---|
| Market cap | 254.58M | 115.23M | 227.69M | 430.72M | 48.44M | 15.64M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.1 | -1.5 | 3.8 | -6.4 | -1.6 | -0.4 |
| Price/book | -25.6 | 0.7 | 4.3 | 1.5 | 4.3 | 0.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +63.35% | −57.14% | −39.07% | −20.06% | −37.50% | −88.47% |
| Today | +11.22% | +2.19% | +9.57% | +2.19% | −3.48% | −7.72% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ALEC news ›Alector, Inc. (NASDAQ:ALEC) Stock Has Average Price Target of $4.62
Posted by Kim Johansen on Nov 3rd, 2026 Read Our Latest Research Report on Alector Alector, Inc (NASDAQ: ALEC) is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company’s research…
ALEC chief executive Mark Harvey-Sutton steps down
The voice of the bush since 1885, Countryman provides WA’s best and most comprehensive agricultural news, with dedicated sections for news, livestock, wool, opinion, machinery, real estate, and social pictures. Our weekly newspaper offers…
Head-To-Head Comparison: CG Oncology (NASDAQ:CGON) and Alector (NASDAQ:ALEC)
Posted by Sarita Garza on Nov 2nd, 2026 CG Oncology (NASDAQ:CGON – Get Free Report) and Alector (NASDAQ:ALEC – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses based on…
Alector: Maintaining "Hold" ABC Platform Transition And GCase Partnership With Roche
Alector (ALEC) holds steady despite trial failures, pivoting to ABC platform and Roche deal extending cash to 2029. - Alector maintains a "Hold" rating after major clinical setbacks and GSK partnership termination. - Despite failed…
Alector Announces Pricing of Underwritten Offering
The Daily Tribune News SOUTH SAN FRANCISCO, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (âAlector,â Nasdaq: ALEC), a biotechnology company focused on developing therapies to counteract the devastating progression of…
Alector rises after pricing $75M equity offering
Alector (ALEC) stock jumps after a $75M equity offering priced at $2.05/share. Read more here. - Shares of Alector (ALEC) added more than 10% in the premarket on Friday after the neurology-focused biotech priced an underwritten equity…
Alectra Inc. appoints Nadira Singh as Executive Vice President, Chief Financial Officer
The Manila Times MISSISSAUGA, Ontario, Oct. 16, 2026 (GLOBE NEWSWIRE) -- Brian Bentz, President and CEO of Alectra Inc., announced today that Nadira Singh has been appointed Executive Vice President, Chief Financ
Alector CEO receives 217,500-share stock grant
Alector, Inc. (NASDAQ: ALEC) is a South San Francisco–based biotech developing genetically informed therapies and BBB platform programs for neurodegenerative diseases. Alector CEO receives 217,500-share stock grant Exercising repriced…
Alector CFO receives 190,000 options and stock grant
Alector, Inc. (NASDAQ: ALEC) is a South San Francisco–based biotech developing genetically informed therapies and BBB platform programs for neurodegenerative diseases. Alector CFO receives 190,000 options and stock grant The 44,567…
Alector awards Grace Wong-Sarad 83,435 options
Alector, Inc. (NASDAQ: ALEC) is a South San Francisco–based biotech developing genetically informed therapies and BBB platform programs for neurodegenerative diseases. Alector awards Grace Wong-Sarad 83,435 options The repricing leaves the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net9
- markets.businessinsider.com5
- seekingalpha.com4
- manilatimes.net2
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 40 articles, not a forecast.